Now showing items 1-4 of 4

  • Characterisation of cysteamine prodrugs for the treatment of cystinosis and evaluation of liquid fill technology. 

    McCormick, John James (Robert Gordon University Faculty of Health and Social Care. School of Pharmacy and Life Sciences, 2016-05)
    MCCORMICK, J.J. 2016. Characterisation of cysteamine prodrugs for the treatment of cystinosis and evaluation of liquid fill technology. Robert Gordon University, MRes thesis.
    Cystinosis is a rare, autosomal, recessive disease characterised by raised levels of the amino acid cystine in the cells of most organs in the body which can cause organ damage. The treatment involves the oral administration ...
  • Formulation studies on cysteamine for the treatment of nephropathic cystinosis. 

    Buchan, Barbara Elizabeth (Robert Gordon University School of Pharmacy and Life Sciences, 2011-08)
    Nephropathic cystinosis is a rare autosomal recessive disease characterised by raised lysosomal levels of cystine in the cells of almost all organs. It is treated by regular oral and topical administration of the aminothiol, ...
  • Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis. 

    McKenzie, Barbara; Kay, Graeme; Matthews, Kerr H.; Knott, Rachel M.; Cairns, Donald (Elsevier https://doi.org/10.1016/j.ijpharm.2016.10.044, 2016-10-19)
    MCKENZIE, B., KAY, G., MATTHEWS, K.H., KNOTT, R. and CAIRNS, D. 2016. Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis. International journal of pharmaceutics [online], 515(1-2), pages 575-582. Available from: https://doi.org/10.1016/j.ijpharm.2016.10.044
    Nephropathic cystinosis is a rare autosomal recessive disease characterised by raised lysosomal levels of cystine in the cells of all organs. It is treated by regular administration of the aminothiol, cysteamine. Corneal ...
  • Suppository formulations as a potential treatment for nephropathic cystinosis. 

    McKenzie, Barbara; Kay, Graeme; Matthews, Kerr H.; Cairns, Donald (Elsevier https://doi.org/10.1002/jps.23246, 2012-07-06)
    BUCHAN, B., KAY, G., MATTHEWS, K.H. and CAIRNS, D. 2012. Suppository formulations as a potential treatment for nephropathic cystinosis. Journal of pharmaceutical sciences [online], 101(10), pages 3729-2738. Available from: https://doi.org/10.1002/jps.23246
    Nephropathic cystinosis is a rare autosomal recessive disease characterised by raised lysosomal levels of cystine in the cells of all the organs. It is treated by the 6-h oral administration of the aminothiol, cysteamine, ...